- Report
- August 2025
- 193 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- August 2024
- 322 Pages
Global
From €3754EUR$4,200USD£3,208GBP
- Report
- August 2025
- 199 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- August 2025
- 184 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- August 2025
- 198 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- August 2025
- 188 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
From €3128EUR$3,500USD£2,673GBP
- Report
- July 2025
- 180 Pages
Global
From €4022EUR$4,500USD£3,437GBP
- Report
- June 2025
- 182 Pages
Global
From €4022EUR$4,500USD£3,437GBP
- Report
- October 2024
- 82 Pages
India
From €3128EUR$3,500USD£2,673GBP
- Report
- August 2023
- 75 Pages
Canada
From €3128EUR$3,500USD£2,673GBP
- Report
- August 2023
- 74 Pages
United States
From €3128EUR$3,500USD£2,673GBP
- Report
- July 2024
- 152 Pages
Global
From €4245EUR$4,750USD£3,628GBP
- Report
- April 2025
- 140 Pages
Global
From €5318EUR$5,950USD£4,545GBP
- Report
- September 2025
- 85 Pages
India
From €3128EUR$3,500USD£2,673GBP
- Report
- March 2025
- 120 Pages
North America
From €3575EUR$4,000USD£3,055GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3128EUR$3,500USD£2,673GBP
- Report
- December 2024
- 87 Pages
Spain
From €3128EUR$3,500USD£2,673GBP
- Report
- August 2024
- 80 Pages
United States
From €3128EUR$3,500USD£2,673GBP
- Report
- August 2024
- 80 Pages
Spain
From €3128EUR$3,500USD£2,673GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more